Merck CEO & Kimmel’s Return 9/24/25
The FDA has approved the injectable version of Merck’s cancer therapy Keytruda. Merck CEO Robert Davis discusses the pricing of this drug and others with CNBC’s Angelica Peebles, Joe Kernen, Becky Quick, and Andrew Ross Sorkin. Davis also stands firm on the safety of vaccines and weighs in on the Trump administration’s agenda for health care. Jimmy Kimmel has returned to ABC’s airwaves. Puck’s Matt Belloni discusses the host’s temporary suspension, Kimmel’s response, and the contractual obligations of Disney’s affiliates Nexstar and Sinclair. Plus, the U.S. has barred Iran’s diplomats from shopping at wholesale stores like Costco without permission. Matt Belloni - 15:12 Robert Davis - 28:47 In this episode Matt Belloni, @mattbelloni Joe Kernen, @JoeSquawk Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin Katie Kramer, @Kramer_Katie
You May Also Like

Mad Money w/ Jim Cramer
CNBC

Know Your Risk Podcast
Know Your Risk Radio

Marketplace
Marketplace

Bloomberg Talks
Bloomberg

CNBC Business News Update
CNBC

CFO Podcast
Peter De Roeck

The Ramsey Show Highlights
Ramsey Network

Power Lunch
CNBC

Mission Matters Business Podcast with Adam Torres
Adam Torres

Founder's Story
IBH Media
Community discussion